Ligand Pharmaceuticals Incorporated (LGND) Insider Trading

Total insider buys:
  • $5,339,328.39
Total insider sells:
  • $218,162,557.55
Most recent insider trade:
  • Sept. 23, 2024
Most active insider trader:
  • John L Higgins
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 16, 2013CFO7,500$42.75Sell$320,625.00
Aug. 16, 2013CEO10,000$42.85Sell$428,500.00
Aug. 16, 2013VP14,583$42.63Sell$621,673.29
June 28, 2013COO1,059$17.36Buy$18,384.24
May 10, 2013VP4,000$26.66Sell$106,640.00
Jan. 23, 2013Major Shareholder39,600$19.78Buy$783,288.00
Dec. 14, 2012Major Shareholder5,386$18.63Buy$100,341.18
Dec. 6, 2012Major Shareholder50,100$17.94Buy$898,794.00
Dec. 5, 2012CEO2,000$18.03Buy$36,060.00
Oct. 31, 2012Major Shareholder16,591$15.19Buy$252,017.29
Aug. 29, 2012Director2,743$16.36Buy$44,875.48
First«4 of 4»Last
  • Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.

  • The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Charles S Berkman, Matthew E Korenberg, Todd C Davis, Octavio Espinoza, Andrew Reardon, Bvf Partners L P/Il, Stephen L Sabba, John L Lamattina, David M Knott, Melanie J Herman, Bvf Partners P/Il, Sunil Patel, Matthew Foehr, David Knott, Nishan M Desilva, Charles Berkman, John Sharp, John Higgins, Todd Davis, John Lamattina, Melanie J. Herman, and John W. Kozarich

  • The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.

  • Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.

  • Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.

  • The most recent insider trade for Ligand Pharmaceuticals Incorporated was on Sept. 23, 2024.

  • The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Bvf Partners L P/Il with a total value of $898,794.00 on Dec. 6, 2012.

  • The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.